<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>S. K.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Ryu</surname>
    <given-names>J. W.</given-names>
   </name>
   <name>
    <surname>Ryu</surname>
    <given-names>T. Y.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>J. H.</given-names>
   </name>
   <name>
    <surname>Oh</surname>
    <given-names>J. H.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer.</article-title>
  <source>
   <italic>Int. J. Oncol.</italic>
  </source>
  <volume>54</volume>
  <fpage>65</fpage>â€“
  <lpage>76</lpage>.
  <pub-id pub-id-type="pmid">30365075</pub-id>
 </mixed-citation>
</ref>
